DCT

1:11-cv-02037

Purdue Pharma LP v. Teva Pharma USA Inc

General

Filed

03/23/11

Cause of ActionPatent Infringement

SectorBiotech

Status

Closed (01/22/14)

Patent Owner

NPE (L)

SourcePACER

Plaintiff

Party

Name	Ratings
Purdue Pharma LP NPE	L2A
Rhodes Technologies NPE	L2A
Purdue Pharmaceuticals LP NPE	L2A
PF Laboratories Inc	L2A
Board Of Regents Of University Of Texas System NPE	L1C
Grunenthal GmbH	L1C

Attorney

Name	Ratings
Finnegan Henderson Farabow Garrett & Dunner LLP	L5C
Basil J. Lewris	L4B
Jennifer H. Roscetti	L3B
Anthony C. Tridico	L3B
Sarah E. Craven	L3B
Joann M. Neth	L3B
Erin Sommers	L1C
Marianne S. Terrot	L1C
Ropes & Gray LLP	L4B
Robert J. Goldman	L4A
Pablo D. Hendler	L4A
Rebecca Rabenstein	L3B
Thomas A. Wang	L3B
Kelly L. Baxter	L3C
Crystal L. Parker	L2C
Vikram A. Mathrani	L2C
Fish & Neave	L4B
Sona De	L4A
Banner & Witcoff LTD	L3B
Robert F. Altherr, Jr.	L4D
Joseph M. Skerpon	L2C
Dale H. Hoscheit	L1C
R KunstadtLocal	L1B
Ilaria Maggioni	L1B
Robert M. Kunstadt	L1B
Wilk Auslander LLPLocal	L1C
Stephen D. Hoffman	L1C

Defendant

Party

Name	Ratings
Teva Pharmaceuticals USA Inc	L5E
Noramco Inc	L5A

Attorney

Name	Ratings
Goodwin Procter LLP	L4E
David M. Hashmall	L4E
Akin Gump Strauss Hauer & Feld LLP	L3A
Barbara L. Mullin	L4A
Angela Verrecchio	L4A
Steven D. Maslowski	L4A
Matthew A. Pearson	L3B
Neil Duchez	L1C
Karen R. Poppel	L1C
Carlson Caspers Vandenburgh Lindquist Schuman PA	L2D
Jennell C. Bilek	L5E
Alexandra Olson	L4C
Mark D. Schuman	L4D
Sarah M. Stensland	L4D
Todd S. Werner	L4D
Samuel T. Lockner	L4E